Collaboration between industry and health professionals benefits patients. It is a relationship that has delivered numerous innovative medicines and changed the way many diseases impact on our lives. Industry and health professionals collaborate in a range of activities from clinical research, sharing best clinical practice and exchanging information on how new medicines fit in to the patient pathway. Bringing greater transparency to this, already well-regulated, vital relationship is about strengthening the basis for collaboration in the future. Society has increasingly high expectations for transparency, none more so than in healthcare (EFPIA).

Eisai wants to ensure it meets those expectations.

This note accompanies the disclosure made by Eisai under EFPIA and national pharma association codes on disclosure of Transfers of Value (ToV) from pharmaceutical companies to Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs). This note includes a general summary and any country specific considerations.

Eisai AB
Svärdvägen 3A
SE-182 33 Danderyd
Tel: +46 (0)8 501 01 600
Fax: +46 (0)8 501 01 699
Medical Information

Eisai Methodological note 2022 Transparency payments 2021 Transparency payments 2020 Transparency payments 2019 Transparency payments 2018 Transparency payments 2017 Transparency payments 2016 Transparency payments 2015 Transparency payments Eisai Disclosure Self Certification